Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.0006 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.39 | 0.002 |